During the past decade, Monticello Cancer Center conducted 139 clinical trials. In the 10-year time frame, 139 clinical trials started and 12 clinical trials were completed, i.e. on average, 8.6% percent of trials that started reached the finish line to date. In the past 5 years, 78 clinical trials started and 12 clinical trials were completed. i.e. 15.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Monticello Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 58 trials, followed by "Alliance for Clinical Trials in Oncology" with 29 trials sponsored, "SWOG Cancer Research Network" with 19 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 15 trials sponsored and "NRG Oncology" with 15 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Monticello Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 85 trials as a collaborator, "NRG Oncology" with 9 trials as a collaborator, "Canadian Cancer Trials Group" with 7 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Monticello Cancer Center" are "Stage IV Lung Cancer AJCC v8" (9 trials), "Invasive Breast Carcinoma" (7 trials), "Anatomic Stage II Breast Cancer AJCC v8" (6 trials), "Anatomic Stage III Breast Cancer AJCC v8" (6 trials) and "Anatomic Stage IIIA Breast Cancer AJCC v8" (6 trials). Many other conditions were trialed in "Monticello Cancer Center" in a lesser frequency.

Most popular intervention types in "Monticello Cancer Center" are "Drug" (109 trials), "Other" (80 trials), "Biological" (54 trials), "Procedure" (48 trials) and "Radiation" (21 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (37 trials), "Questionnaire Administration" (35 trials), "Computed Tomography" (28 trials), "Biospecimen Collection" (27 trials) and "Nivolumab" (21 trials). Other intervention names were less common.

The vast majority of trials in "Monticello Cancer Center" are 124 trials for "All" genders, 16 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "Monticello Cancer Center". undefined are not yet recruiting, 66 are recruiting, 62 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Monticello Cancer Center, 7 suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Monticello Cancer Center, 1 "Phase 1" clinical trials were conducted, 74 "Phase 2" clinical trials and 65 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".